Rockefeller University: Unique Characteristics of a Rare Liver Cancer Identified as Clinical Trial of New Treatment Begins
January 18, 2025
January 18, 2025
NEW YORK, Jan. 18 (TNSjou) -- Rockefeller University issued the following news:
Like many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky few--in this case, children, adolescents, and young adults. Because its symptoms can vary from person to person, it's often missed or misdiagnosed until it has metastasized and becomes lethal. Moreover, drug therapies for common liver cancers are not just useless for FLC patients but ac . . .
Like many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky few--in this case, children, adolescents, and young adults. Because its symptoms can vary from person to person, it's often missed or misdiagnosed until it has metastasized and becomes lethal. Moreover, drug therapies for common liver cancers are not just useless for FLC patients but ac . . .